Vivani reported Phase 1 success for its exenatide implant and shared preclinical semaglutide data showing 231-day weight loss ...

Get the detailed quarterly/annual income statement for Vivani Medical, Inc. (VANI). Find out the revenue, expenses and profit or loss over the last fiscal year.

Find the latest Vivani Medical, Inc. (VANI) stock quote, history, news and other vital information to help you with your stock trading and investing.